4.82
-0.07(-1.43%)
Currency In USD
| Previous Close | 4.89 |
| Open | 4.76 |
| Day High | 4.9 |
| Day Low | 4.67 |
| 52-Week High | 175.98 |
| 52-Week Low | 4.67 |
| Volume | 18,070 |
| Average Volume | 1.07M |
| Market Cap | 548,646 |
| PE | -0.02 |
| EPS | -313.92 |
| Moving Average 50 Days | 8.18 |
| Moving Average 200 Days | 35.02 |
| Change | -0.07 |
If you invested $1000 in Nuwellis, Inc. (NUWE) 10 years ago, it would be worth $0 as of September 08, 2025 at a share price of $4.82. Whereas If you bought $1000 worth of Nuwellis, Inc. (NUWE) shares 5 years ago, it would be worth $0 as of September 08, 2025 at a share price of $4.82.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Nuwellis Introduces New 24-Hour Aquadex™ Circuit to Support Hospital-Based Outpatient and Short-Term Fluid Management
GlobeNewswire Inc.
Sep 04, 2025 12:15 PM GMT
MINNEAPOLIS, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc., a fluid management company, announced plans to introduce a new 24-hour circuit for Aquadex therapy in the United States this fall. The new circuit is designed for single-day outpatient
Nuwellis Receives FDA 510(k) Clearance for New Dual Lumen Extended Length Catheter
GlobeNewswire Inc.
Aug 21, 2025 12:15 PM GMT
MINNEAPOLIS, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on fluid management, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for a new size of its D
Nuwellis Signs Letter of Intent to Explore Acquisition of Rendiatech Ltd., A Real-Time Fluid Monitoring Company
GlobeNewswire Inc.
Aug 19, 2025 12:15 PM GMT
Proposed acquisition supports strategy to drive technology expansion of fluid management offering to include continuous renal health monitoring technologies supporting the full patient journey, from early risk assessment to targeted fluid removal MIN